3D printing in personalized drug delivery V Jain, N Haider, K Jain Current pharmaceutical design 24 (42), 5062-5071, 2018 | 102 | 2018 |
RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy A Sheikh, S Md, P Kesharwani Journal of Controlled Release 340, 221-242, 2021 | 74 | 2021 |
CD44-targeted nanocarrier for cancer therapy P Kesharwani, R Chadar, A Sheikh, WY Rizg, AY Safhi Frontiers in pharmacology 12, 800481, 2022 | 67 | 2022 |
Gold nanoparticles and gold nanorods in the landscape of cancer therapy P Kesharwani, R Ma, L Sang, M Fatima, A Sheikh, MAS Abourehab, ... Molecular Cancer 22 (1), 98, 2023 | 61 | 2023 |
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer R Chadar, P Kesharwani International Journal of Pharmaceutics 605, 120835, 2021 | 61 | 2021 |
An insight into aptamer engineered dendrimer for cancer therapy A Sheikh, P Kesharwani European Polymer Journal 159, 110746, 2021 | 56 | 2021 |
Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer A Sheikh, S Md, P Kesharwani Biomedicine & Pharmacotherapy 146, 112530, 2022 | 54 | 2022 |
Folic acid conjugated poly (amidoamine) dendrimer as a smart nanocarriers for tracing, imaging, and treating cancers over-expressing folate receptors M Fatima, A Sheikh, N Hasan, A Sahebkar, Y Riadi, P Kesharwani European Polymer Journal 170, 111156, 2022 | 52 | 2022 |
Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics A Sheikh, S Md, NA Alhakamy, P Kesharwani International Journal of Pharmaceutics 620, 121751, 2022 | 45 | 2022 |
Dostarlimab as a miracle drug: rising hope against cancer treatment V Singh, A Sheikh, MAS Abourehab, P Kesharwani Biosensors 12 (8), 617, 2022 | 43 | 2022 |
Recent progress of RGD modified liposomes as multistage rocket against cancer A Sheikh, NA Alhakamy, S Md, P Kesharwani Frontiers in Pharmacology 12, 803304, 2022 | 43 | 2022 |
Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer U Rehman, N Parveen, A Sheikh, MAS Abourehab, A Sahebkar, ... Colloids and Surfaces B: Biointerfaces 218, 112766, 2022 | 37 | 2022 |
A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy P Kesharwani, A Sheikh, MAS Abourehab, R Salve, V Gajbhiye Journal of Drug Delivery Science and Technology 80, 104164, 2023 | 35 | 2023 |
The clinical significance of 4D printing A Sheikh, MAS Abourehab, P Kesharwani Drug Discovery Today 28 (1), 103391, 2023 | 32 | 2023 |
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer Z Liu, N Parveen, U Rehman, A Aziz, A Sheikh, MAS Abourehab, W Guo, ... Molecular Cancer 22 (1), 8, 2023 | 30 | 2023 |
Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer N Hasan, M Imran, M Nadeem, D Jain, K Haider, MMA Rizvi, A Sheikh, ... International Journal of Pharmaceutics 632, 122580, 2023 | 29 | 2023 |
Precision medicine: Ray of hope in overcoming cancer multidrug resistance P Musyuni, J Bai, A Sheikh, KS Vasanthan, GK Jain, MAS Abourehab, ... Drug Resistance Updates 65, 100889, 2022 | 28 | 2022 |
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches N Hasan, A Nadaf, M Imran, U Jiba, A Sheikh, WH Almalki, SS Almujri, ... Molecular cancer 22 (1), 168, 2023 | 27 | 2023 |
Amelioration of full-thickness wound using hesperidin loaded dendrimer-based hydrogel bandages P Gupta, A Sheikh, MAS Abourehab, P Kesharwani Biosensors 12 (7), 462, 2022 | 27 | 2022 |
Itraconazole and difluorinated-curcumin containing chitosan nanoparticle loaded hydrogel for amelioration of onychomycosis P Kesharwani, M Fatima, V Singh, A Sheikh, WH Almalki, V Gajbhiye, ... Biomimetics 7 (4), 206, 2022 | 24 | 2022 |